Literature DB >> 2536534

Reduction of 7-alkoxyresorufins by NADPH-cytochrome P450 reductase and its differential effects on their O-dealkylation by rat liver microsomal cytochrome P450.

D R Dutton1, A Parkinson.   

Abstract

Antibody-inhibition experiments established that the induction of cytochrome P450c is largely responsible for the marked increase in liver microsomal 7-ethoxyresorufin O-dealkylation in rats treated with 3-methylcholanthrene, whereas the induction of cytochrome P450b and/or P450e is largely responsible for the marked increase in 7-pentoxy- and 7-benzyloxyresorufin O-dealkylation in rats treated with phenobarbital. When reconstituted with NADPH-cytochrome P450 reductase and lipid, purified cytochrome P450c catalyzed the O-dealkylation of 7-ethoxyresorufin at a rate of approximately 30 nmol/nmol P450/min, which far exceeded the rate catalyzed by either purified cytochromes P450b and P450e or microsomal cytochrome P450c. In contrast, purified cytochrome P450b and P450e were poor catalysts of the O-dealkylation of 7-pentoxy- and 7-benzyloxyresorufin. However, purified cytochrome P450b is an excellent catalyst of several other reactions, such as the N-demethylation of benzphetamine, the hydroxylation of testosterone, and the O-dealkylation of 7-ethoxycoumarin. The low rate of 7-pentoxyresorufin O-dealkylation catalyzed by purified cytochrome P450b did not reflect a requirement for cytochrome b5, and could not be ascribed to an artifact of the method used to measure the formation of resourufin. The catalytic activity of purified cytochrome P450b toward 7-pentoxyresorufin was consistently low over a range of substrate and lipid concentrations, and was not stimulated by sodium deoxycholate (which stimulates the N-demethylation of benzphatamine by purified cytochrome P450b). Evidence is presented which indicates that cytochrome P450c catalyzes the O-dealkylation of both the oxidized and reduced forms of 7-ethoxyresorufin, with perhaps a slight preference for the reduced form. In contrast, cytochrome P450b preferentially catalyzes the O-dealkylation of the oxidized form of 7-pentoxyresorufin. Conditions that favored formation of the reduced form of 7-ethoxyresorufin tended to stimulate its O-dealkylation by purified cytochrome P450c, whereas conditions that favored formation of the reduced form of 7-pentoxyresorufin decreased its rate of O-dealkylation by purified cytochrome P450b. Such conditions included a molar excess of NADPH-cytochrome P450 reductase over cytochrome P450, the presence of superoxide dismutase, and the presence of DT-diaphorase (liver cytosol).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536534     DOI: 10.1016/0003-9861(89)90329-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Inhibition of cytochrome P450 2B4 by environmentally persistent free radical-containing particulate matter.

Authors:  James R Reed; Albert Leo N dela Cruz; Slawo M Lomnicki; Wayne L Backes
Journal:  Biochem Pharmacol       Date:  2015-03-24       Impact factor: 5.858

2.  The effect of bamboo extract on hepatic biotransforming enzymes--findings from an obese-diabetic mouse model.

Authors:  Cheryl L K Koide; Abby C Collier; Marla J Berry; Jun Panee
Journal:  J Ethnopharmacol       Date:  2010-09-09       Impact factor: 4.360

3.  Environmentally persistent free radicals inhibit cytochrome P450 activity in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Taylor G Ardoin; Barry Dellinger; Slawomir M Lomnicki; Farhana Hasan; Lucy W Kiruri; Wayne L Backes
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-05       Impact factor: 4.219

4.  Association of cytochrome P450 enzymes is a determining factor in their catalytic activity.

Authors:  Eszter Hazai; Zsolt Bikádi; Miklós Simonyi; David Kupfer
Journal:  J Comput Aided Mol Des       Date:  2005-04       Impact factor: 3.686

5.  Inhibition of cytochrome P450 1A2-mediated metabolism and production of reactive oxygen species by heme oxygenase-1 in rat liver microsomes.

Authors:  James R Reed; George F Cawley; Wayne L Backes
Journal:  Drug Metab Lett       Date:  2011-01

6.  Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine.

Authors:  H Konishi; K Morita; T Minouchi; A Yamaji
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.441

7.  Comparative toxicity of four chlorinated dibenzo-p-dioxins (CDDs) and their mixture. Part III: Structure-activity relationship with increased plasma tryptophan levels, but no relationship to hepatic ethoxyresorufin o-deethylase activity.

Authors:  L W Weber; M Lebofsky; B U Stahl; A Kettrup; K Rozman
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

8.  Relationship between acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and disturbance of intermediary metabolism in the Long-Evans rat.

Authors:  F Fan; K K Rozman
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

9.  N-alkylprotoporphyrin formation and hepatic porphyria in dogs after administration of a new antiepileptic drug candidate: mechanism and species specificity.

Authors:  Jean-Marie Nicolas; Hugues Chanteux; Valérie Mancel; Guy-Marie Dubin; Brigitte Gerin; Ludovicus Staelens; Olympe Depelchin; Sophie Kervyn
Journal:  Toxicol Sci       Date:  2014-06-27       Impact factor: 4.849

10.  Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.

Authors:  Christophe Morisseau; Oleg Merzlikin; Amy Lin; Guochun He; Wei Feng; Isela Padilla; Michael S Denison; Isaac N Pessah; Bruce D Hammock
Journal:  Environ Health Perspect       Date:  2009-07-31       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.